Press Release | Thu Jan 3, 2013 7:01am EST

Alkermes Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate

* Reuters is not responsible for the content in this press release.